Skip to main content

Full Schedule

Full Schedule

  • Monday, September 14, 2026
  • 7:00 AM - 4:00 PM EDT
    Registration Hours
  • 7:00 AM - 4:30 PM EDT
    Speaker Ready Room Hours
  • 7:30 AM - 8:30 AM EDT
    Preconference Workshop Networking Breakfast & Welcome
  • 8:30 AM - 4:00 PM EDT
    Behind the Curtain: A Practitioner's Field Guide to Global Health Authority Transparency for Drugs and Biologics
  • 8:30 AM - 4:00 PM EDT
    Drug Development in the EU: Regulatory Standards, Revisions in Legislation, and Support Activities
  • 8:30 AM - 4:00 PM EDT
    Preconference Workshop: Briefing Books that Work: A Storyboarding Method for Meetings, Scientific Advice, and AdComs (Day 1 of 2)
  • 8:30 AM - 4:00 PM EDT
    Preconference Workshop: Co-Development of Drugs and IVD/CDx: From Early Strategy to Commercial Success
  • 8:30 AM - 4:00 PM EDT
    Survivor: The FDA 510(k) and De Novo 50Th Anniversary Program Edition (Day 1 of 2)
  • 8:30 AM - 4:00 PM EDT
    The Ins and Outs of the Commission's MDR and IVDR Targeted Revision Proposal (Day 1 of 2)
  • 12:30 PM - 1:30 PM EDT
    Preconference Workshops: Networking Lunch
  • Tuesday, September 15, 2026
  • 7:00 AM - 4:30 PM EDT
    Speaker Ready Room Hours
  • 7:00 AM - 7:30 PM EDT
    Registration Hours
  • 7:30 AM - 8:30 AM EDT
    Preconference Workshop Networking Breakfast & Welcome
  • 8:30 AM - 4:00 PM EDT
    Briefing Books that Work: A Storyboarding Method for Meetings, Scientific Advice, and AdComs (Day 2 of 2)
  • 8:30 AM - 4:00 PM EDT
    Claiming Your Seat at the Table
  • 8:30 AM - 4:00 PM EDT
    Ethics in Action: Practical Tools for Navigating Regulatory Dilemmas
  • 8:30 AM - 4:00 PM EDT
    Navigating Cell & Gene Therapy US, EU, and Japan Regulatory Strategies
  • 8:30 AM - 4:00 PM EDT
    Preconference Workshops: Regulatory Leadership Bootcamp:  A Skills‑Based Accelerator for Early to Mid‑Career Professionals
  • 8:30 AM - 4:00 PM EDT
    Survivor: The FDA 510(k) and De Novo 50Th Anniversary Program Edition (Day 2 of 2)
  • 8:30 AM - 4:00 PM EDT
    The Ins and Outs of the Commission's MDR and IVDR Targeted Revision Proposal (Day 2 of 2)
  • 10:30 AM - 11:00 AM EDT
    Preconference Workshops: Networking Break
  • 12:30 PM - 1:30 PM EDT
    Preconference Workshops: Networking Lunch
  • 3:00 PM - 3:15 PM EDT
    Preconference Workshops: Networking Break
  • 3:00 PM - 4:00 PM EDT
    Student Career Development Sesson
  • 4:30 PM - 6:00 PM EDT
    RAPS Convergence 2026 Welcome & Opening Plenary
  • 6:00 PM - 7:30 PM EDT
    Opening Networking Reception & Welcome in the Exhibit Hall
  • Wednesday, September 16, 2026
  • 6:30 AM - 5:30 PM EDT
    Registration Hours
  • 6:30 AM - 5:30 PM EDT
    Speaker Ready Room Hours
  • 7:00 AM - 8:00 AM EDT
    Community Gathering (Continental Breakfast)
  • 8:00 AM - 9:00 AM EDT
    Morning Plenary Session
  • 9:15 AM - 10:15 AM EDT
    Advancing Representation in Clinical Trials: Scientific and Operational Strategies for Population-Reflective Enrollment
  • 9:15 AM - 10:30 AM EDT
    Back by Popular Demand: The Evolution of U.S. and EU Regulatory Policies and Excellence
  • 9:15 AM - 10:30 AM EDT
    Biomarker‑Based Endpoints in Drug Development: Scientific Rigor and Regulatory Perspectives
  • 9:15 AM - 10:30 AM EDT
    Diverse Women in Regulatory Affairs: Leadership and Career Pathways
  • 9:15 AM - 10:30 AM EDT
    New Session Topic: Accelerated Drug Development
  • 9:15 AM - 10:30 AM EDT
    New Session Topic: IVDR Revision Proposal
  • 9:15 AM - 10:30 AM EDT
    Small Manufacturers Challenges and Lessons Learned
  • 10:30 AM - 11:00 AM EDT
    Networking Refreshment Break in Exhibit Hall
  • 10:30 AM - 1:00 PM EDT
    Exclusive Exhibit Hall Hours: Networking & Presentations
  • 10:30 AM - 4:30 PM EDT
    Exhibit Hall Hours
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: Including Regulatory Requirements in Partnership Agreements for Joint Drug and Combination Product Development
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: Maximizing the Potential of Meetings with the FDA
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: QMSR Transition: What Gaps Are Manufacturers Underestimating and How to Prioritize Remediation
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: FDA Pre-Submission Strategy: How to Plan, Execute, and Maximize Regulatory Feedback
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: The Invisible Dossier: Networking as a Regulatory Requirement
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: When is the Same Moiety Different? The Clinical Superiority Provisions of FDA's Orphan Drug Regulations
  • 11:30 AM - 1:00 PM EDT
    Networking Lunch in Exhibit Hall
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: Breakthrough Designation: Is It Right for Your Device?
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: The US Reimbursement Landscape: Understanding Shifts and Changes in the Drug Pricing Narrative
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: The Volunteer Sandbox: Accelerating Regulatory Leadership through RAPS
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: From Access to Insight: A Call for Transparency and Disclosure
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Reg Ops to Reg Strategy and Everything In-Between: How to Become a Well-Rounded RA Professional
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Submission Strategies for Medical Devices in Brazil - Submission Pathways & Ongoing Challenges
  • 1:00 PM - 2:00 PM EDT
    Animal Health Drugs: The Approval & Lifecyle Process
  • 1:00 PM - 2:00 PM EDT
    Clinical Data Transferability: Strategies for Utilizing Cross-Regional Evidence in Regulatory Submissions
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: China Device Updates
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: CMC
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: MDR/IVDR State of Play
  • 1:00 PM - 2:00 PM EDT
    Regulatory Mentoring in the Workplace
  • 2:15 PM - 3:15 PM EDT
    Financial Literacy for Regulatory Affairs
  • 2:15 PM - 3:15 PM EDT
    Impact of AI on Regulatory Workforce.
  • 2:15 PM - 3:15 PM EDT
    In-Silico Trials - Global Perspectives and Solutions
  • 2:15 PM - 3:15 PM EDT
    Leveraging External Controls to Advance Global Regulatory Decision-Making
  • 2:15 PM - 3:15 PM EDT
    New Approach Methodologies (NAMs) in Preclinical Drug Development: Discussion of the Current Global Regulatory Landscape
  • 2:15 PM - 3:15 PM EDT
    New Session Topic: Direct to Consumer
  • 2:15 PM - 3:15 PM EDT
    New Session Topic: MDR Transition
  • 2:15 PM - 3:15 PM EDT
    Sticky Wickets in Statutory Authority: CDER’s Workarounds, Remote Participation, and the Legal Limits of FDA Inspection Power
  • 3:15 PM - 3:45 PM EDT
    Networking Refreshment Break in Exhibit Hall
  • 3:15 PM - 4:30 PM EDT
    Exclusive Exhibit Hall Hours: Networking & Presentations
  • 4:00 PM - 4:30 PM EDT
    Solutions Circle: How to 10x Productivity as a Regulatory Affairs Professional using AI
  • 4:00 PM - 4:30 PM EDT
    Solutions Circle: Navigating Social Media in Pharmacovigilance: Regulatory Uncertainty, Data Challenges, and Strategic Considerations for RA Professionals
  • 4:00 PM - 4:30 PM EDT
    Solutions Circle: Risk Assessment: Common Failures in Identification and Implementation of ISO 14971 as Seen by NBs
  • 4:30 PM - 5:30 PM EDT
    FemTech and Beyond: Addressing Sex-Based Disparities in Medical Devices and Pharmaceuticals
  • 4:30 PM - 5:30 PM EDT
    Global Biosimilarity Assessments: Key Regulatory Changes Impacting Biosimilar Development Strategy
  • 4:30 PM - 5:30 PM EDT
    ICH M4Q(R2) as the Inflection Point: Digitizing CMC Submissions and Operationalizing Responsible AI/ML
  • 4:30 PM - 5:30 PM EDT
    Navigating Global eIFU Excellence: Leveraging US and EU Best Practices for Strategic Implementation
  • 4:30 PM - 5:30 PM EDT
    New Session Topic: EUDAMED
  • 4:30 PM - 5:30 PM EDT
    The Convergence of Regulatory and Politics: A Closer Look at Congressional Proposals to Reform FDA
  • 5:45 PM - 7:15 PM EDT
    Honoring Excellence: RAPS 2026 Awards Celebration (Invitation Only)
  • 7:30 PM - 10:00 PM EDT
    Convergence Networking Party (Offsite Event, Location to Be Announced Soon)
  • Thursday, September 17, 2026
  • 6:30 AM - 4:30 PM EDT
    Speaker Ready Room Hours
  • 7:00 AM - 8:00 AM EDT
    Community Gathering (Continental Breakfast)
  • 7:00 AM - 3:00 PM EDT
    Registration Hours
  • 8:00 AM - 9:00 AM EDT
    Morning Plenary Session
  • 9:15 AM - 10:30 AM EDT
    Beyond Technical Expertise: Power Skills for Regulatory Leadership and Career Growth
  • 9:15 AM - 10:30 AM EDT
    EU Pharma Legislation Update
  • 9:15 AM - 10:30 AM EDT
    IMDRF Overview
  • 9:15 AM - 10:30 AM EDT
    Move real-world evidence from buzzword to valuable regulatory asset
  • 9:15 AM - 10:30 AM EDT
    New Session Topic: Post Approval Changes
  • 9:15 AM - 10:30 AM EDT
    Optimizing Regulatory Strategies to Mitigate Drug Shortages Throughout the Lifecycle of an Approved Drug Product
  • 9:15 AM - 10:30 AM EDT
    Unifying Drug and Device Change Management Frameworks - A US Focus
  • 10:30 AM - 11:00 AM EDT
    Networking Refreshment Break in Exhibit Hall
  • 10:30 AM - 1:00 PM EDT
    Exclusive Exhibit Hall Hours: Networking & Presentations
  • 10:30 AM - 3:30 PM EDT
    Exhibit Hall Hours
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: Including Regulatory Requirements in Partnership Agreements for Joint Drug and Combination Product Development (Repeat)
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: Maximizing the Potential of Meetings with the FDA (Repeat)
  • 10:35 AM - 11:05 AM EDT
    Solutions Circle: URRA vs. Hazard Analysis: Aligning Scope, Format, and Expectations
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: eSTAR in Practice: What Actually Works (and What Doesn't)
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: The Invisible Dossier: Networking as a Regulatory Requirement (Repeat)
  • 11:10 AM - 11:40 AM EDT
    Solutions Circle: When is the Same Moiety Different? The Clinical Superiority Provisions of FDA's Orphan Drug Regulations (Repeat)
  • 11:30 AM - 1:00 PM EDT
    Networking Lunch in Exhibit Hall
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: FDA-Required Safety Labeling Changes: Navigating the Agency's New Guidance
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: The US Reimbursement Landscape: Understanding Shifts and Changes in the Drug Pricing Narrative (Repeat)
  • 11:45 AM - 12:15 PM EDT
    Solutions Circle: The Volunteer Sandbox: Accelerating Regulatory Leadership through RAPS (Repeat)
  • 11:45 AM - 12:45 PM EDT
    Solutions Circle: Regulatory Challenges and Opportunities in Companion Diagnostics Clinical Trials
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Navigating Lay Language 2026 and Beyond
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Reg Ops to Reg Strategy and Everything In-Between: How to Become a Well-Rounded RA Professional (Repeat)
  • 12:20 PM - 12:50 PM EDT
    Solutions Circle: Understanding the Medical Devices Approvals by the Reliance Route in Brazil: Criteria & Benefits
  • 1:00 PM - 2:00 PM EDT
    EMEA Regional Updates
  • 1:00 PM - 2:00 PM EDT
    Enhancing Medical Device Safety Through Implementing Cybersecurity Guidance
  • 1:00 PM - 2:00 PM EDT
    FDA Forecast 2027: What the FDA Has in Store for Pharmaceuticals and Biotechnology Products
  • 1:00 PM - 2:00 PM EDT
    How to Conduct Successful Interviews
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: China Drug Approvals
  • 1:00 PM - 2:00 PM EDT
    New Session Topic: Wearables
  • 1:00 PM - 2:00 PM EDT
    The Economics of Compliance Where International Trade Intersects with cGMP
  • 2:00 PM - 2:30 PM EDT
    Networking Refreshment Break in Exhibit Hall
  • 2:00 PM - 3:15 PM EDT
    Exclusive Exhibit Hall Hours: Networking & Presentations
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Poster Display: From First Aid to Performance Aid: Regulating Smelling Salts in Sports
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Poster Display: Regulatory and Operational Impact of Decentralized Clinical Trials on Development Efficiency and Market Access
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Poster Display:
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Presentation: Bridging the Regulatory Chasm: A Global Harmonized Framework (GHF) for AI-Augmented Pharmacovigilance
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Presentation: Evaluating 3rd Party Pre-Trained AI Models for use in Software Development of Medical Devices
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Presentation: Navigating Legal Landscape for Operationalizing Site Specific Acceptance Testing of FDA Authorized AI Medical Devices
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Presentation: Pharmaceutical liability in commercial spaceflight: rethinking the duty to warn in microgravity
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Presentation: Preparing for the EU AI Act: Regulatory Readiness for Medical Devices and Software
  • 2:00 PM - 3:15 PM EDT
    Student Capstone Presentation: Turning Compliance into Competitive Advantage: AI-Driven Regulatory Pathways for Medical Device Innovators
  • 2:30 PM - 2:50 PM EDT
    Solutions Circle: Navigating the UK Regulatory Landscape: UK MDR Amendments and Impact Incl Alternative Routes
  • 2:30 PM - 2:50 PM EDT
    Solutions Circle: Regulatory CMC Agency Queries and RFIs
  • 3:15 PM - 4:15 PM EDT
    Achieving the Fastest Simultaneous Global Filings: the Tarlatamab Blueprint
  • 3:15 PM - 4:15 PM EDT
    Closing the Gap: Timely Evidence for Pregnancy and Breastfeeding in Clinical Trials
  • 3:15 PM - 4:15 PM EDT
    Environmental Convergence: Horizontal EU Requirements Reshaping Medical Device and IVD Regulation
  • 3:15 PM - 4:15 PM EDT
    From Profile to Post: Making LinkedIn Work for Your Career
  • 3:15 PM - 4:15 PM EDT
    Navigating the New US & EU Rare Disease Regulatory Framework and Global Harmonization Efforts
  • 3:15 PM - 4:15 PM EDT
    New Session Topic: IVD Clinical
  • 3:15 PM - 4:15 PM EDT
    Predetermined Change Control Plans (PCCPs) Across the Device Lifecycle: From Premarket Strategy to Postmarket Execution
  • 4:30 PM - 5:30 PM EDT
    Advertisement & Promotional Materials: Making Decisions in an Ambiguous World
  • 4:30 PM - 5:30 PM EDT
    Best Practices in MDR/IVDR Conformity Assessment Processes: Lessons Learned for SaMD and AI-Integrated Medical Devices
  • 4:30 PM - 5:30 PM EDT
    Global Regulatory Convergence for Artificial Intelligence in the Medical Product Lifecycle
  • 4:30 PM - 5:30 PM EDT
    Leveraging CRL Trends to Streamline Submissions and Market Access
  • 4:30 PM - 5:30 PM EDT
    Navigating FDA Biocompatibility: From Strategy to Successful Submission in the New Era
  • 4:30 PM - 5:30 PM EDT
    New Session Topic: Pediatric Rare Disease
  • 4:30 PM - 5:30 PM EDT
    Utilizing Non-COA Patient Experience Data in Drug Development and Regulatory Decision-Making: Recent and Emerging Developments
  • 6:00 PM - 9:00 PM EDT
    RAPS Convergence 50th Anniversary & Closing Party Celebration at NASCAR Hall of Fame